The global market for COVID-19 Vaccines is estimated at 6.4 Billion Doses in 2023 and is projected to reach 0 Million Doses by 2030, growing at a CAGR of -100% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Key Insights:
- Regional Analysis: Gain insights into the U.S. market, estimated at 285 Million Doses in 2023, and China, forecasted to grow at an impressive -100% CAGR to reach 0 Million Doses by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global COVID-19 Vaccines Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global COVID-19 Vaccines Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global COVID-19 Vaccines Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as AstraZeneca PLC, Aurobindo Pharma Ltd., Amyris, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 358 Featured):
- AstraZeneca PLC
- Aurobindo Pharma Ltd.
- Amyris, Inc.
- AnGes, Inc.
- Altimmune, Inc.
- Arcturus Therapeutics, Inc.
- ADImmune Corporation
- AdaptVac
- AJ Vaccines
- Batavia Biosciences BV
- ARTES Biotechnology GmbH
- Baylor College of Medicine
- baseclick GmbH
- Barcelona Supercomputing Center
- Akston Biosciences Corporation
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYREGIONAL MARKET PERSPECTIVECompetitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)WORLD COVID-19 VACCINE BRANDSSELECT CORPORATE DEVELOPMENTS IN THE COVID-19 VACCINE MARKET: 2021IV. COMPETITION
MARKET OVERVIEW
mRNA: A NEW APPROACH TO MEDICINE
MARKET DYNAMICS
GLOBAL MARKET PERSPECTIVE
VACCINES FOR KIDS
THE UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
ASIA-PACIFIC
THE MIDDLE EAST
AFRICA
LATIN AMERICA
FOCUS ON THE FRONTRUNNERS
INITIATIVES FOR EQUITable DISTRIBUTION OF VACCINES
KEY VACCINE TECHNOLOGY PLATFORMS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca PLC
- Aurobindo Pharma Ltd.
- Amyris, Inc.
- AnGes, Inc.
- Altimmune, Inc.
- Arcturus Therapeutics, Inc.
- ADImmune Corporation
- AdaptVac
- AJ Vaccines
- Batavia Biosciences BV
- ARTES Biotechnology GmbH
- Baylor College of Medicine
- baseclick GmbH
- Barcelona Supercomputing Center
- Akston Biosciences Corporation
